Monopar Therapeutics Inc (MNPR)

Feb 01, 2025

(MNPR) Trading Report - Stock Traders Daily

Feb 01, 2025

Jan 27, 2025

What's Going On With Cancer-Focused Monopar Therapeutics Stock Today? - MSN

Jan 27, 2025

Jan 26, 2025

What is HC Wainwright’s Forecast for MNPR FY2026 Earnings? - Defense World

Jan 26, 2025

Jan 24, 2025

Monopar Therapeutics Stock Hits 52-Week High at $38.91 - MSN

Jan 24, 2025

Jan 24, 2025

Analysts Set Expectations for MNPR FY2029 Earnings - MarketBeat

Jan 24, 2025

Jan 24, 2025

What is HC Wainwright's Forecast for MNPR FY2026 Earnings? - MarketBeat

Jan 24, 2025

Jan 24, 2025

Monopar Therapeutics Stock Hits 52-Week High at $38.91 By Investing.com - Investing.com South Africa

Jan 24, 2025

Jan 23, 2025

Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics - PR Newswire

Jan 23, 2025

Jan 23, 2025

Monopar Therapeutics price target raised to $40 from $22 at H.C. Wainwright - Yahoo Finance

Jan 23, 2025

Jan 22, 2025

Monopar Therapeutics (NASDAQ:MNPR) Price Target Raised to $40.00 - MarketBeat

Jan 22, 2025

Jan 21, 2025

All You Need to Know About Monopar Therapeutics (MNPR) Rating Upgrade to Buy - MSN

Jan 21, 2025

Jan 21, 2025

Up 1,000% in 2024, Wall Street Believes This Growth Stock Can Still Skyrocket - MSN

Jan 21, 2025

Jan 12, 2025

Piper Sandler Begins Coverage on Monopar Therapeutics (NASDAQ:MNPR) - Defense World

Jan 12, 2025

Jan 11, 2025

Piper Sandler Initiates Coverage of Monopar Therapeutics (MNPR) with Overweight Recommendation - MSN

Jan 11, 2025

Jan 10, 2025

(MNPR) Trading Advice - Stock Traders Daily

Jan 10, 2025

Jan 10, 2025

Piper Sandler Initiates Coverage on Monopar Therapeutics (NASDAQ:MNPR) - MarketBeat

Jan 10, 2025

Jan 10, 2025

Brookline Capital Management Comments on MNPR Q1 Earnings - Defense World

Jan 10, 2025

Jan 09, 2025

Brookline Capital Management Predicts MNPR Q1 Earnings - MarketBeat

Jan 09, 2025

Jan 08, 2025

JANUS HENDERSON GROUP PLC Acquires Additional Shares in Monopar Therapeutics Inc - GuruFocus.com

Jan 08, 2025

Jan 02, 2025

MNPR Stock Skyrockets 384% in 3 Months After Deal With AZN - MSN

Jan 02, 2025

Dec 31, 2024

How the (MNPR) price action is used to our Advantage - Stock Traders Daily

Dec 31, 2024

Dec 31, 2024

These 2 Monster Growth Stocks Skyrocketed Over 1,000% This Year — Here’s What Analysts Expect in 2025 - Yahoo Finance

Dec 31, 2024

Dec 26, 2024

Monopar Therapeutics Inc. Enters Into Underwritten Registered Offering and Concurrent Private PlacementOn December 20, 2024, Monopar Therapeutics Inc. (NASDAQ: MNPR) finalized an Underwriting Agreement with Piper Sandler & Co. to conduct an Und - Defense World

Dec 26, 2024

Dec 26, 2024

What Awaits These 4 Biotech Stocks That More Than Doubled in 2024 - Zacks Investment Research

Dec 26, 2024

Dec 23, 2024

Monopar: Radiopharmaceutical Company With 2 Radioisotope Development Pathways (MNPR) - Seeking Alpha

Dec 23, 2024

Dec 20, 2024

(MNPR) Technical Data - Stock Traders Daily

Dec 20, 2024

Dec 20, 2024

Monopar Therapeutics announces pricing of $40M public offering of common stock - MSN

Dec 20, 2024

Dec 20, 2024

Best-Performing Small-Cap Stocks of 2024 - Investing.com

Dec 20, 2024

Dec 20, 2024

Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants - The Manila Times

Dec 20, 2024

Dec 20, 2024

Monopar Therapeutics sets stock and warrant offering prices - Investing.com

Dec 20, 2024

Dec 20, 2024

Here's What Could Help Monopar Therapeutics (MNPR) Maintain Its Recent Price Strength - MSN

Dec 20, 2024

Dec 10, 2024

When the Price of (MNPR) Talks, People Listen - Stock Traders Daily

Dec 10, 2024

Dec 06, 2024

Monopar Therapeutics Achieves Milestone in Cancer Treatment - TipRanks

Dec 06, 2024

Dec 05, 2024

Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu - EIN News

Dec 05, 2024

Dec 05, 2024

Monopar's Novel Radiopharmaceutical MNPR-101-Lu Achieves First-Ever Patient Dosing Milestone - StockTitan

Dec 05, 2024

Dec 04, 2024

Oral Mucositis Market expected to rise | Companies- Galera Therapeutics, Soligenix, Izun Pharma, MitoImmune Therapeutics, Tosk, Cellix Bio, Enzychem Lifesciences, Monopar Therapeutics - The Globe and Mail

Dec 04, 2024

Dec 03, 2024

What Makes Monopar Therapeutics (MNPR) a Good Fit for 'Trend Investing' - MSN

Dec 03, 2024

Dec 03, 2024

Monopar to Present at the 36th Annual Piper Sandler Healthcare Conference - The Manila Times

Dec 03, 2024

Dec 03, 2024

3 Momentum Stocks Soaring Into 2025 and Beyond - sharewise

Dec 03, 2024

Nov 25, 2024

Monopar Therapeutics: Radiopharmaceuticals And Rare Disease Potential In Focus - Seeking Alpha

Nov 25, 2024

Nov 19, 2024

(MNPR) Proactive Strategies - Stock Traders Daily

Nov 19, 2024

Nov 14, 2024

HC Wainwright Has Positive Estimate for MNPR FY2024 Earnings - MarketBeat

Nov 14, 2024

Nov 11, 2024

HC Wainwright Issues Positive Forecast for Monopar Therapeutics (NASDAQ:MNPR) Stock Price - MarketBeat

Nov 11, 2024

Nov 11, 2024

Monopar Therapeutics stock target lifted, buy rating on AstraZeneca deal By Investing.com - Investing.com UK

Nov 11, 2024

Nov 10, 2024

Monopar Therapeutics (NASDAQ:MNPR) Releases Financial Results for the Third Quarter 2024Monopar Therapeutics Inc. recently disclosed its financial results for the third quarter ending September 30, 2024, in a press release dated November 8, 2024. The - Defense World

Nov 10, 2024

Nov 09, 2024

MNPRMonopar Therapeutics Inc. Latest Stock News & Market Updates - StockTitan

Nov 09, 2024

Nov 08, 2024

(MNPR) Investment Report - Stock Traders Daily

Nov 08, 2024

Nov 08, 2024

Monopar Therapeutics Inc Reports Q3 2024 GAAP EPS of -$0.37 and Net Loss of $1.3 Million - GuruFocus.com

Nov 08, 2024

Nov 08, 2024

Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments - The Manila Times

Nov 08, 2024